The influence of glycated hemoglobin in a study comparing patients who required hospitalization or not

Hyperglycemia can cause deleterious effects in the body as inflammation. The glycated hemoglobin (HbA1c) plays a key role in monitoring of glycemic for reporting the retrospective index of plasma glucose. To evaluate the HbA1c as a prognostic marker in relation to need or not of hospitalization in patients with other diseases. A study conducted at the Hospital Samaritano lasting five yrs. The HbA1c was analyzed outpatient and hospitalized for various clinical conditions. With regard to inpatients, according to capillary hyperglycemia observed at admission, verified by a Glucose approved by the FDA (Food and Drug Administration) Precision XTra (Abbott) was collected HbA1c, according to NUMAD Protocol (Multidisciplinary Center for Assistance the diabetic). It was considered hyperglycemia blood glucose values> 140 mg dl-, according to the American Diabetes Association. Outpatients collected according to routine medical request. HbA1c was analyzed by High Performance Liquide Chromatography (HPLC) method. Parameters were established for analysis of glycated hemoglobin equal to or less than 6.9%, 7 to 9%, and greater than 9%. Statistical differences were considered significant at p <0.05.